Evidence map›Paper›PMID 36851349›Full record

ArticleVaccines2023

Cohort-Specific Peptide Reagents Broaden Depth and Breadth Estimates of the CD8 T Cell Response to HIV-1 Gag Potential T Cell Epitopes.

Clive M Michelo, Andrew Fiore-Gartland, Jama A Dalel, Peter Hayes, Jianming Tang, Edward McGowan, William Kilembe, Natalia Fernandez, Jill Gilmour, Eric Hunter

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Clive M MicheloCenter for Family Health Research Zambia, PostNet 412, P/Bag E891, B22/737 Bwembelelo, Emmasdale, Lusaka 10101, Zambia.
Andrew Fiore-GartlandVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.ORCID 0000-0001-7627-2166
Jama A DalelIAVI Human Immunology Laboratory, Imperial College, London SW10 9NH, UK.
Peter HayesIAVI Human Immunology Laboratory, Imperial College, London SW10 9NH, UK.ORCID 0000-0002-1251-934X
Jianming TangDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0003-0137-7486
Edward McGowanIAVI Human Immunology Laboratory, Imperial College, London SW10 9NH, UK.
William KilembeCenter for Family Health Research Zambia, PostNet 412, P/Bag E891, B22/737 Bwembelelo, Emmasdale, Lusaka 10101, Zambia.
Natalia FernandezIAVI Human Immunology Laboratory, Imperial College, London SW10 9NH, UK.ORCID 0000-0002-4213-079X
Jill GilmourIAVI Human Immunology Laboratory, Imperial College, London SW10 9NH, UK.
Eric HunterCenter for Family Health Research Zambia, PostNet 412, P/Bag E891, B22/737 Bwembelelo, Emmasdale, Lusaka 10101, Zambia.ORCID 0000-0002-4273-8631
Imperial College London · GBEmory University · USFred Hutch Cancer Center · USUniversity of Alabama at Birmingham · US

Funding

SDMC: HIV Vaccine Trials NetworkUM1AI068635 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Peter B. Gilbert, Yunda Huang · 2011 to 2026
$385.9M
Virologic Correlates of Heterosexual TransmissionR01AI051231 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ALLEN, TODD M, HUNTER, ERIC · 2002 to 2022
$9.9M
Deciphering the impact of sex in early subtype C HIV infection and during HARTR01AI172740 · NIAID · EMORY UNIVERSITY · PI Eric Hunter · 2022 to 2026
$4.3M
NIAID NIH HHS R01 AI051231NIAID NIH HHS R01 AI172740NIAID NIH HHS UM1 AI068635Wellcome TrustWellcome Trust 107752/Z/15/Z
6 · The paper itself

Abstract

An effective HIV vaccine will need to stimulate immune responses against the sequence diversity presented in circulating virus strains. In this study, we evaluate breadth and depth estimates of potential T-cell epitopes (PTEs) in transmitted founder virus sequence-derived cohort-specific peptide reagents against reagents representative of consensus and global sequences. CD8 T-cells from twenty-six HIV-1+ PBMC donor samples, obtained at 1-year post estimated date of infection, were evaluated. ELISpot assays compared responses to 15mer consensus (

Indexed as

CD8 T-cellepitope-mappingHIV-1HIV-1 vaccine

Identifiers

PMID36851349
PMCPMC9961105
OpenAlexW4321372677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.